Our dedicated and quality-focused workforce has been developing and manufacturing silicones since 1977 in Cleveland, Ohio.
Largest R&D in Class
If we don’t have the precise silicone needed for an electronics application, our scientists will customize formulations in our lab.
We have introduced nearly 80 new products to market since 2018; technologies include alcohol and oxime cure silicones, UV cure, and UV alkoxy dual cure silicones, and fast curing two-part silicones.
ISO 9001:2015 (QMS with Design), IATF 16949:2016 (QMS with Design)
Rapid and Responsive
Small but mighty, we are able to quickly deliver solutions thanks to our synchronized commercialization team.
Novagard is a Woman Owned Small Business (WOSB) and a Women’s Business Enterprise (WBE).
Novagard is a member of NextFlex, a consortium of companies, academic institutions, nonprofits, and government partners who share the goal of advancing U.S. manufacturing of Flexible Hybrid Electronics (FHE). The NextFlex community collectively facilitates innovation, narrows the manufacturing workforce gap, and promotes sustainable manufacturing ecosystems.
A Strategic Focus on Electronics
Novagard is ready to help you identify the exact potting and encapsulating product, conformal coating, or thermal interface management solution that not only reduces processing time and cost, but also delivers world class protection of critical components.
We engineer our own polymers, adhesion promoters, and cross-linkers. Our R&D team, the largest in its class and growing, is battle tested. We listen, iterate, and deliver solutions that meet our customers’ precision needs.
Sarah E. Nash has led Novagard since 2018 and is its Majority Owner, Chairman, CEO, and President. She has built a company that embraces diversity of thought, experience, and human capital as a competitive advantage, and harnesses strategic investments in capital, R&D, and manufacturing capabilities to deliver innovative solutions to customer requirements. Sarah retired in 2005 as a Vice Chairman for J.P. Morgan’s Global Investment Bank with broad M&A, capital market, and lending experience across all industry groups, including financial services. She is also presently a board director for several public and private companies and nonprofit organizations. In addition, Sarah invests in privately held biotech and other venture-backed companies.